GeneTex
  • Country / Location Selection

United States (US)

Tafazzin / TAZ antibody [C2C3], C-term

Anti-Tafazzin / TAZ antibody [C2C3], C-term used in IHC (Paraffin sections) (IHC-P). GTX106271

Cat No. GTX106271

Host

Rabbit

Clonality

Polyclonal

Isotype

IgG

Application

IHC-P

Reactivity

Human
Package
100 μl ($379),
25 μl ($169)

APPLICATION

Application Note

*Optimal dilutions/concentrations should be determined by the researcher.
Application Dilution
IHC-P 1:100-1:1000
Not tested in other applications.

Calculated MW

33 kDa. ( Note )

Positive Control

Synthetic peptide: 1:8,000

Predict Reactivity

Chimpanzee(>80% identity)

PROPERTIES

Form

Liquid

Buffer

1XPBS (pH7), 10% Glycerol

Preservative

0.01% Thimerosal

Storage

Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.

Concentration

1 mg/ml (Please refer to the vial label for the specific concentration.)

Antigen Species

Human

Immunogen

Carrier-protein conjugated synthetic peptide encompassing a sequence within the C-terminus region of human Tafazzin / TAZ. The exact sequence is proprietary.

Purification

Purified by antigen-affinity chromatography.

Conjugation

Unconjugated

RRID

AB_1241380

Note

For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.

TARGET

Synonyms

tafazzin , BTHS , CMD3A , EFE , EFE2 , G4.5 , LVNCX , Taz1

Cellular Localization

Isoform 1: Membrane; Single-pass membrane protein , Isoform 2: Cytoplasm , Isoform 3: Membrane; Single-pass membrane protein , Isoform 4: Membrane; Single-pass membrane protein , Isoform 5: Membrane; Single-pass membrane protein , Isoform 6: Cytoplasm , I

Background

This gene encodes a protein that is expressed at high levels in cardiac and skeletal muscle. Mutations in this gene have been associated with a number of clinical disorders including Barth syndrome, dilated cardiomyopathy (DCM), hypertrophic DCM, endocardial fibroelastosis, and left ventricular noncompaction (LVNC). Multiple transcript variants encoding different isoforms have been described. A long form and a short form of each of these isoforms is produced; the short form lacks a hydrophobic leader sequence and may exist as a cytoplasmic protein rather than being membrane-bound. Other alternatively spliced transcripts have been described but the full-length nature of all these transcripts is not known. [provided by RefSeq]

Database

Research Area

DATA IMAGES

Anti-Tafazzin / TAZ antibody [C2C3], C-term used in IHC (Paraffin sections) (IHC-P). GTX106271

GTX106271 IHC-P Image

TAZ antibody [C2C3], C-term detects TAZ protein at cytoplasm on human placenta by immunohistochemical analysis.
Sample: Paraffin-embedded placenta.
TAZ antibody [C2C3], C-term (GTX106271) dilution: 1:100.

Antigen Retrieval: Citrate buffer, pH 6.0, 15 min

REFERENCE

There are currently no references for Tafazzin / TAZ antibody [C2C3], C-term (GTX106271). Be the first to share your publications with this product.

REVIEW

There are currently no reviews for Tafazzin / TAZ antibody [C2C3], C-term (GTX106271). Be the first to share your experience with this product.
SDS
PBS.pdf
Glycerol.pdf
Thimerosal.pdf
Package List Price ($)
$ 379
$ 169